Keith Bentlage
Mr. Keith Bentlage, Acting Vice President, Head of Program and Alliance Management
Keith joined as Acting vice president, Head of Program and Alliance Management;
Keith most recently served as President at Simurgh Consulting, where he was responsible for strategy, clinical development, regulatory affairs, business development, and portfolio and alliance management consulting. He led drug development teams, driving collaboration among employees, consultants, academic experts, vendors and partners. Prior to Simurgh Consulting, Keith held a variety of program and alliance leadership positions at Shire, BMS, Merck, Emergent Biosolutions, and Pfizer. In these roles, Keith led a range of leading drug development programs including BMS’ Early Stage (Myostatin ®and Late Stage (Baraclude®, Opdivo®) & Merck’s Lotrim®, Afrin PureSea®,Pfizer’s Aricept®, Rebif®, Relpax® and Zoloft®.
Keith earned master’s degrees in biotechnology from Johns Hopkins University, an MBA degree in Washington University (St. Louis), and his undergraduate degree in Biochemistry at the University of Missouri.